Geneseeq Technology Inc.

Geneseeq Technology Inc. company information, Employees & Contact Information

Geneseeq Technology Inc. is a research-driven global leader in precision oncology, advancing cancer detection, diagnosis, and treatment through cutting-edge next-generation sequencing (NGS) technologies. With headquarters in Canada and China, Geneseeq operates CAP-, CLIA-, and ISO 15189-accredited laboratories for central laboratory testing, and is ISO 13485-certified for the development and manufacturing of both in vitro diagnostic (IVD) and research use only (RUO) testing kits. Our comprehensive testing portfolio includes: -Pan-cancer panels covering over 400 genes; -Cancer-type-specific panels tailored for solid tumors and hematologic malignancies; -Minimal residual disease (MRD) monitoring technologies; -Multi-cancer early detection (MCED) solutions, including CanScan®, which holds both CE mark and FDA Breakthrough Device Designation; -CE-IVD and NMPA-approved NGS-based assays, including tumor mutational burden (TMB) testing. Geneseeq’s testing services and products are widely adopted by more than 8,000 oncologist partners across 20+ countries and regions. We are actively involved in over 2,700 research collaborations with pharmaceutical and academic partners, providing high-quality genomic data to support biomarker discovery, clinical development, and translational research. Driven by innovation and a commitment to quality, Geneseeq delivers integrated NGS solutions that help guide personalized treatment decisions and accelerate the global adoption of precision cancer care.
Looking for a particular Geneseeq Technology Inc. employee's phone or email?

Geneseeq Technology Inc. Questions

News

Geneseeq's Breakthrough Cancer Detection Blood Test Published in Nature Medicine - PR Newswire

Geneseeq's Breakthrough Cancer Detection Blood Test Published in Nature Medicine PR Newswire

Geneseeq’s new blood test may detect early-stage pancreatic cancer - Rare Cancer News

Geneseeq’s new blood test may detect early-stage pancreatic cancer Rare Cancer News

GeneseeqPrime® Gains FDA 510(k) Clearance - PR Newswire

GeneseeqPrime® Gains FDA 510(k) Clearance PR Newswire

Geneseeq Unveils Groundbreaking Blood Test for Early Detection of Pancreatic Cancer - PR Newswire

Geneseeq Unveils Groundbreaking Blood Test for Early Detection of Pancreatic Cancer PR Newswire

Early diagnosis of brain metastases using cerebrospinal fluid cell-free DNA-based breakpoint motif and mutational features in lung cancer - Wiley Online Library

Early diagnosis of brain metastases using cerebrospinal fluid cell-free DNA-based breakpoint motif and mutational features in lung cancer Wiley Online Library

Geneseeq scores FDA breakthrough designation for cancer detection device - Medical Device Network

Geneseeq scores FDA breakthrough designation for cancer detection device Medical Device Network

No Routine Cancer Screening Option? New MCED Tests May Help - Medscape

No Routine Cancer Screening Option? New MCED Tests May Help Medscape

Comprehensive characterization of PKHD1 mutation in human colon cancer - Han - 2024 - Cancer Medicine - Wiley Online Library

Comprehensive characterization of PKHD1 mutation in human colon cancer - Han - 2024 - Cancer Medicine Wiley Online Library

Geneseeq Gains CE Marks for NGS-based Test Kits for Solid Tumors and Hematological Cancer - PR Newswire Canada

Geneseeq Gains CE Marks for NGS-based Test Kits for Solid Tumors and Hematological Cancer PR Newswire Canada

Molecular landscape and therapeutic alterations in Asian soft‐tissue sarcoma patients - Gan - 2022 - Cancer Medicine - Wiley Online Library

Molecular landscape and therapeutic alterations in Asian soft‐tissue sarcoma patients - Gan - 2022 - Cancer Medicine Wiley Online Library

GENESEEQ RECEIVES CHINESE NMPA APPROVAL FOR LUNG CANCER TUMOR MUTATIONAL BURDEN NGS TEST KIT - PR Newswire

GENESEEQ RECEIVES CHINESE NMPA APPROVAL FOR LUNG CANCER TUMOR MUTATIONAL BURDEN NGS TEST KIT PR Newswire

Molecular risk factors for locoregional recurrence in resected non‐small cell lung cancer - Wiley Online Library

Molecular risk factors for locoregional recurrence in resected non‐small cell lung cancer Wiley Online Library

Geneseeq Publishes Promising Early Lung Cancer Detection Results in AJRCCM - PR Newswire

Geneseeq Publishes Promising Early Lung Cancer Detection Results in AJRCCM PR Newswire

Capture-based next-generation sequencing reveals multiple actionable mutations in cancer patients failed in traditional testing - Wiley Online Library

Capture-based next-generation sequencing reveals multiple actionable mutations in cancer patients failed in traditional testing Wiley Online Library

Top Geneseeq Technology Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant